IL142362A0 - Ureidopiperidine derivatives as selective human nk3 receptor antagonists - Google Patents
Ureidopiperidine derivatives as selective human nk3 receptor antagonistsInfo
- Publication number
- IL142362A0 IL142362A0 IL14236299A IL14236299A IL142362A0 IL 142362 A0 IL142362 A0 IL 142362A0 IL 14236299 A IL14236299 A IL 14236299A IL 14236299 A IL14236299 A IL 14236299A IL 142362 A0 IL142362 A0 IL 142362A0
- Authority
- IL
- Israel
- Prior art keywords
- ureidopiperidine
- derivatives
- receptor antagonists
- selective human
- selective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9812859A FR2784377B3 (fr) | 1998-10-09 | 1998-10-09 | Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant |
| PCT/FR1999/002355 WO2000021931A1 (fr) | 1998-10-09 | 1999-10-04 | Derives d'ureidopiperidine comme antagonistes selectifs des recepteurs nk3 humains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL142362A0 true IL142362A0 (en) | 2002-03-10 |
Family
ID=9531536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14236299A IL142362A0 (en) | 1998-10-09 | 1999-10-04 | Ureidopiperidine derivatives as selective human nk3 receptor antagonists |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6465489B1 (tr) |
| EP (1) | EP1119552A1 (tr) |
| JP (1) | JP2002527423A (tr) |
| KR (1) | KR20010085903A (tr) |
| CN (1) | CN1133622C (tr) |
| AR (1) | AR029148A1 (tr) |
| AU (1) | AU751592B2 (tr) |
| BR (1) | BR9914397A (tr) |
| CA (1) | CA2346729A1 (tr) |
| CO (1) | CO5180555A1 (tr) |
| DZ (1) | DZ2905A1 (tr) |
| EA (1) | EA003613B1 (tr) |
| EE (1) | EE200100214A (tr) |
| FR (1) | FR2784377B3 (tr) |
| HU (1) | HUP0201709A3 (tr) |
| IL (1) | IL142362A0 (tr) |
| IS (1) | IS5897A (tr) |
| NO (1) | NO20011779L (tr) |
| NZ (1) | NZ510779A (tr) |
| PL (1) | PL347910A1 (tr) |
| SK (1) | SK4642001A3 (tr) |
| TR (1) | TR200101030T2 (tr) |
| TW (1) | TW539669B (tr) |
| WO (1) | WO2000021931A1 (tr) |
| YU (1) | YU26001A (tr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001068604A2 (en) | 2000-03-14 | 2001-09-20 | Sepracor, Inc. | 3-substituted piperidines comprising urea functionality, and methods of use thereof |
| US20060128752A1 (en) * | 2002-07-03 | 2006-06-15 | Giuseppe Alvaro | Chemical compounds |
| US20110144081A1 (en) * | 2009-12-15 | 2011-06-16 | Henner Knust | Pyrrolidine derivatives |
| US9554659B2 (en) | 2012-10-22 | 2017-01-31 | Uwm Research Foundation, Inc. | Infant sleep pod |
| EP3881843A4 (en) * | 2018-11-15 | 2022-08-03 | Kyushu University, National University Corporation | PROPHYLACTIC OR THERAPEUTIC AGENT AND MEDICAL COMPOSITION FOR IL-31 MEDIATED DISEASE |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99320A (en) | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
| FR2676055B1 (fr) | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| FR2688219B1 (fr) * | 1992-03-03 | 1994-07-08 | Sanofi Elf | Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant. |
| FR2719311B1 (fr) | 1994-03-18 | 1998-06-26 | Sanofi Sa | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. |
| FR2738819B1 (fr) | 1995-09-14 | 1997-12-05 | Sanofi Sa | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
| AU4176997A (en) | 1996-09-16 | 1998-04-02 | Warner-Lambert Company | 3-alkyl-3-phenyl-piperidines |
-
1998
- 1998-10-09 FR FR9812859A patent/FR2784377B3/fr not_active Expired - Lifetime
-
1999
- 1999-10-04 SK SK464-2001A patent/SK4642001A3/sk unknown
- 1999-10-04 NZ NZ510779A patent/NZ510779A/en unknown
- 1999-10-04 HU HU0201709A patent/HUP0201709A3/hu unknown
- 1999-10-04 EE EEP200100214A patent/EE200100214A/xx unknown
- 1999-10-04 CN CNB998142085A patent/CN1133622C/zh not_active Expired - Fee Related
- 1999-10-04 AU AU59887/99A patent/AU751592B2/en not_active Ceased
- 1999-10-04 EA EA200100299A patent/EA003613B1/ru not_active IP Right Cessation
- 1999-10-04 PL PL99347910A patent/PL347910A1/xx not_active Application Discontinuation
- 1999-10-04 WO PCT/FR1999/002355 patent/WO2000021931A1/fr not_active Application Discontinuation
- 1999-10-04 JP JP2000575840A patent/JP2002527423A/ja active Pending
- 1999-10-04 BR BR9914397-6A patent/BR9914397A/pt not_active IP Right Cessation
- 1999-10-04 CA CA002346729A patent/CA2346729A1/en not_active Abandoned
- 1999-10-04 YU YU26001A patent/YU26001A/sh unknown
- 1999-10-04 EP EP99970379A patent/EP1119552A1/fr not_active Withdrawn
- 1999-10-04 TR TR2001/01030T patent/TR200101030T2/tr unknown
- 1999-10-04 IL IL14236299A patent/IL142362A0/xx unknown
- 1999-10-04 US US09/806,878 patent/US6465489B1/en not_active Expired - Fee Related
- 1999-10-04 KR KR1020017004456A patent/KR20010085903A/ko not_active Application Discontinuation
- 1999-10-05 TW TW088117155A patent/TW539669B/zh not_active IP Right Cessation
- 1999-10-06 DZ DZ990205A patent/DZ2905A1/xx active
- 1999-10-07 AR ARP990105081A patent/AR029148A1/es not_active Application Discontinuation
- 1999-10-08 CO CO99064055A patent/CO5180555A1/es not_active Application Discontinuation
-
2001
- 2001-03-16 IS IS5897A patent/IS5897A/is unknown
- 2001-04-06 NO NO20011779A patent/NO20011779L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ510779A (en) | 2003-07-25 |
| CO5180555A1 (es) | 2002-07-30 |
| TW539669B (en) | 2003-07-01 |
| TR200101030T2 (tr) | 2001-08-21 |
| IS5897A (is) | 2001-03-16 |
| EE200100214A (et) | 2002-08-15 |
| EA200100299A1 (ru) | 2001-10-22 |
| SK4642001A3 (en) | 2001-09-11 |
| NO20011779D0 (no) | 2001-04-06 |
| DZ2905A1 (fr) | 2004-03-01 |
| JP2002527423A (ja) | 2002-08-27 |
| CN1133622C (zh) | 2004-01-07 |
| AU751592B2 (en) | 2002-08-22 |
| KR20010085903A (ko) | 2001-09-07 |
| AU5988799A (en) | 2000-05-01 |
| AR029148A1 (es) | 2003-06-18 |
| FR2784377B3 (fr) | 2000-11-17 |
| EP1119552A1 (fr) | 2001-08-01 |
| CA2346729A1 (en) | 2000-04-20 |
| NO20011779L (no) | 2001-06-07 |
| US6465489B1 (en) | 2002-10-15 |
| YU26001A (sh) | 2003-04-30 |
| HUP0201709A2 (en) | 2002-09-28 |
| EA003613B1 (ru) | 2003-06-26 |
| BR9914397A (pt) | 2001-06-26 |
| CN1329594A (zh) | 2002-01-02 |
| FR2784377A1 (fr) | 2000-04-14 |
| PL347910A1 (en) | 2002-04-22 |
| HUP0201709A3 (en) | 2003-03-28 |
| WO2000021931A1 (fr) | 2000-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL143226A0 (en) | Pyrrolidine derivatives-ccr-3 receptor antagonists | |
| IL125903A0 (en) | Indole derivatives useful as endothelin receptor antagonists | |
| HU9601529D0 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists | |
| IL150033A0 (en) | Selective neurokinin antagonists | |
| GB2343891B (en) | 4-Aroyl-piperidine CCR-3 receptor antagonists | |
| PL356990A1 (en) | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists | |
| SG80041A1 (en) | Muscarinic receptor antagonists | |
| IL142045A0 (en) | Naphthalenecarboxamides as tachykinin receptor antagonists | |
| EP0929218A4 (en) | R2Y RECEPTOR ANTAGONISTS | |
| IL146151A0 (en) | Human-g-protein receptor | |
| GR3034847T3 (en) | Indoline derivatives useful as 5-ht-2c receptor antagonists | |
| EP1084142A4 (en) | GPR35A RECEIVER | |
| IL142362A0 (en) | Ureidopiperidine derivatives as selective human nk3 receptor antagonists | |
| HUP9903439A3 (en) | Indoline derivatives useful as 5-ht-2c receptor antagonists | |
| GB9820014D0 (en) | Receptor antagonists and uses thereof | |
| EP1047424A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| EP1039903A4 (en) | INTERLEUKIN-8 RECEPTOR ANTAGONISTS | |
| AU2574801A (en) | Selective iGLUR5 receptor antagonists | |
| EP1131335A4 (en) | 7TM RECEPTOR HLWAR77 | |
| EP1100813A4 (en) | HUMAN BOMBESIN RECEPTOR 3Sb POLYPEPTIDE | |
| EP1083909A4 (en) | hCEPR RECEPTOR | |
| IL140983A0 (en) | Il-8 receptor antagonists | |
| GB9811283D0 (en) | Vironectin receptor antagonists | |
| EP1109565A4 (en) | GABAB1AA RECEPTOR | |
| GB9814737D0 (en) | Fibrinogen receptor antagonists |